Page 1 of 3 pages :  1 2 3 >

1. Hem/Onc News: Recent Clinical Findings

H&O May 2011 Volume 9, Issue 5

Stacey Small

Download PDF

2. Advances in LLM: Hypomethylating Agents in Myelodysplastic Syndromes

H&O February 2011 Volume 9, Issue 2

William G. Blum, MD

Download PDF

3. Advances in Hematology: The Importance of Antibody Detection and Identification in the Chronically Transfused Patient

H&O September 2010 Volume 8, Issue 9

S. Gerald Sandler, MD

Download PDF

4. Advances in LLM: Update on Treatments for Patients With Myelodysplastic Syndrome

H&O June 2010 Volume 8, Issue 6

Guillermo Garcia-Manero, MD

Download PDF

5. Feature Article: Hypomethylating Agent Induction Therapy Followed By Hematopoietic Cell Transplantation Is Feasible in Patients With Myelodysplastic Syndromes

H&O January 2010 Volume 8, Issue 1

Christopher R. Cogle, MD, Iman Imanirad, MD, Laura E. Wiggins, PharmD, Jack Hsu, MD, Randy Brown, MD, Juan C. Scornik, MD, and John R. Wingard, MD

Download PDF

6. Hem/Onc News: Recent Clinical Findings

H&O August 2009 Volume 7, Issue 8

Ellie Vershvovsky

Download PDF

7. Hem/Onc News: Recent Clinical Advances

H&O April 2009 Volume 7, Issue 4

Ellie Vershvovsky

Download PDF

8. Clinical Roundtable Monograph: Recent Advances in Low- and Intermediate-1–Risk Myelodysplastic Syndrome: Developing a Consensus for Optimal Therapy

H&O December 2008 Volume 6, Issue 12 , 19

Richard Stone, MD, Mikkael Sekeres, MD, MS, Guillermo Garcia-Manero, MD, and Roger M. Lyons, MD, FACP

Download PDF

9. Clinical Update: Treating Low-risk Myelodysplastic Syndromes in the Community Setting

H&O June 2008 Volume 6, Issue 6

Larry D. Cripe, MD

Download PDF

10. Advances in LLM: Lenalidomide in Myelodysplastic Syndromes

H&O April 2008 Volume 6, Issue 4

Alan F. List, MD

Download PDF

Page 1 of 3 pages :  1 2 3 >